These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Suppression of eEF2 phosphorylation alleviates synaptic failure and cognitive deficits in mouse models of Down syndrome. Wang X; Yang Q; Zhou X; Keene CD; Ryazanov AG; Ma T Alzheimers Dement; 2024 Aug; 20(8):5357-5374. PubMed ID: 38934363 [TBL] [Abstract][Full Text] [Related]
4. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Perfeito R; Cunha-Oliveira T; Rego AC Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292 [TBL] [Abstract][Full Text] [Related]
5. The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans. Bornhorst J; Chakraborty S; Meyer S; Lohren H; Brinkhaus SG; Knight AL; Caldwell KA; Caldwell GA; Karst U; Schwerdtle T; Bowman A; Aschner M Metallomics; 2014 Mar; 6(3):476-90. PubMed ID: 24452053 [TBL] [Abstract][Full Text] [Related]
6. Osmotic stress induced toxicity exacerbates Parkinson's associated effects via dysregulation of autophagy in transgenic C. elegans model. Jadiya P; Mir SS; Nazir A Cell Signal; 2018 May; 45():71-80. PubMed ID: 29410282 [TBL] [Abstract][Full Text] [Related]
7. Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. Hu D; Sun X; Liao X; Zhang X; Zarabi S; Schimmer A; Hong Y; Ford C; Luo Y; Qi X Acta Neuropathol; 2019 Jun; 137(6):939-960. PubMed ID: 30877431 [TBL] [Abstract][Full Text] [Related]
8. Early Parkinson's disease symptoms in α-synuclein transgenic monkeys. Niu Y; Guo X; Chen Y; Wang CE; Gao J; Yang W; Kang Y; Si W; Wang H; Yang SH; Li S; Ji W; Li XJ Hum Mol Genet; 2015 Apr; 24(8):2308-17. PubMed ID: 25552648 [TBL] [Abstract][Full Text] [Related]
9. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase. Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587 [TBL] [Abstract][Full Text] [Related]
11. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease. Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974 [TBL] [Abstract][Full Text] [Related]
12. LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons. Henderson MX; Peng C; Trojanowski JQ; Lee VMY Acta Neuropathol Commun; 2018 May; 6(1):45. PubMed ID: 29855356 [TBL] [Abstract][Full Text] [Related]
13. Maackiain Ameliorates 6-Hydroxydopamine and Tsai RT; Tsai CW; Liu SP; Gao JX; Kuo YH; Chao PM; Hung HS; Shyu WC; Lin SZ; Fu RH Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585871 [TBL] [Abstract][Full Text] [Related]
14. Regulation of the Elongation Phase of Protein Synthesis Enhances Translation Accuracy and Modulates Lifespan. Xie J; de Souza Alves V; von der Haar T; O'Keefe L; Lenchine RV; Jensen KB; Liu R; Coldwell MJ; Wang X; Proud CG Curr Biol; 2019 Mar; 29(5):737-749.e5. PubMed ID: 30773367 [TBL] [Abstract][Full Text] [Related]
15. α-Synuclein in Parkinson's disease: pathogenic function and translation into animal models. Eschbach J; Danzer KM Neurodegener Dis; 2014; 14(1):1-17. PubMed ID: 24080741 [TBL] [Abstract][Full Text] [Related]